Page 2 - Replicate Bioscience News Today

With the release of its pediatric COVID-19 vaccine, Pfizer switched the buffer used in its formulation to increase the stability of the product, allowing it to remain at refrigerator temperatures for longer. The Food and Drug Administration OK'd the change, which is also being made to some doses for teens and adults. Social media posts, however, misleadingly suggest that the ingredient swap is dangerous or was added to prevent heart attacks in children.

After the success of the mRNA vaccines from Pfizer and Moderna, some San Diego-based companies are developing the next generation of the technology, called self-replicating RNA.